Skip to main navigation
Skip to search
Skip to main content
Sort by
Neuroscience
Antigen
100%
Tissue Plasminogen Activator
100%
Recombinant DNA
100%
Blood Plasma
100%
Myocardial Infarction
100%
Thrombin
66%
Prothrombin
66%
Fibrinogen
66%
Plasminogen
66%
Protamine
66%
Antiplasmin
66%
Fibrinogen Degradation Product
66%
Thromboplastin
33%
Fibrinolytic System
33%
Keyphrases
Myocardial Infarction
100%
Recombinant Tissue Plasminogen Activator (rt-PA)
100%
Clinical Pharmacology
100%
Tissue Plasminogen Activator (t-PA)
100%
Recombinant DNA Technology
100%
Fibrinogen
25%
Prothrombin Time
25%
Thrombin Time
25%
Protamine
25%
Plasminogen
25%
Fibrinogen Degradation Products
25%
Antiplasmin
25%
Bleeding
12%
Pharmacologic Effects
12%
Blood Samples
12%
Bi-exponential
12%
Intracoronary
12%
Functional Activity
12%
Activated Partial Thromboplastin Time (aPTT)
12%
Fibrinolytic Activity
12%
Bleeding Complications
12%
Antigen Levels
12%
Pharmacological Properties
12%
Drug-induced
12%
Coronary Thrombolysis
12%
Coronary Thrombosis
12%
Fibrinolytic System
12%
Antigen Activity
12%
PA Protein
12%
Short-term Infusion
12%
Change in Concentration
12%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Clinical Pharmacology
100%
Tissue Plasminogen Activator
100%
Recombinant DNA
100%
Triphenyltetrazolium
100%
Antigen
37%
Thrombin
25%
Fibrinogen
25%
Fibrinolytic Agent
25%
Protamine
25%
Plasminogen
25%
Prothrombin
25%
Antiplasmin
25%
Fibrinogen Degradation Product
25%
Bleeding
12%
Thromboplastin
12%
Coronary Artery Thrombosis
12%